Investigating how seizures affect tau protein spread in Alzheimer's Disease

Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease

NIH-funded research University of Pennsylvania · NIH-11080330

This study is looking at how seizures might make Alzheimer's disease worse by spreading a harmful protein in the brain, and it hopes to find new ways to help people with Alzheimer's.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11080330 on NIH RePORTER

What this research studies

This research explores the relationship between seizures and the spread of tau protein in Alzheimer's Disease (AD). It aims to understand how neuronal hyperactivity, induced by seizures, can exacerbate AD pathology. Using advanced mouse models and human brain tissue, the study will measure the accumulation of tau and its effects on cognitive decline. By examining the mechanisms of tau transmissibility, the research seeks to identify potential targets for therapeutic intervention in AD patients.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease, particularly those who have experienced seizures.

Not a fit: Patients with Alzheimer's Disease who have not experienced seizures may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies that slow down or modify the progression of Alzheimer's Disease.

How similar studies have performed: Previous research has shown promising results in understanding the role of tau in Alzheimer's Disease, but this specific approach using seizure models is relatively novel.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.